Watch these entrepreneurs

Harvard professor and startup builder Omid Farokhzad has long been a big player in the Boston biotech scene. But he decided to go west for his next act. On Monday, he launched a new South San Francisco-based company called Seer, which will mine data on protein expression to try to develop liquid biopsies for early disease detection.

Longtime biopharma watchers may recall Jim Bianco, who spent 25 years running a Seattle-based biotech company known first as Cell Therapeutics and later as CTI BioPharma. Bianco’s tenure there was inauspicious — the company failed to make money and faced unfavorable regulatory scrutiny — but now, Bianco is back. He just incorporated Tuhura BioPharma, a new cancer drug company in Seattle, the Puget Sound Business Journal reports.